Search
bioAffinity Technologies Inc
BIAFAdd to Watchlist
0.812USD
+0.008+1.05%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
5.10MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-30No earnings forecast score is currently available for bioAffinity Technologies Inc. The Healthcare Equipment & Supplies industry's average is 7.80. The average price target is 6.00, with a high of 6.00 and a low of 6.00.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
6.000
Target Price
+2190.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
bioAffinity Technologies Inc
BIAF
1
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is bioAffinity Technologies Inc's expected revenue for the next quarter?
bioAffinity Technologies Inc's expected revenue is 1.70M.
What is bioAffinity Technologies Inc's price target?
Analysts forecast that bioAffinity Technologies Inc's price target is USD 6.00, with the highest forecast at USD 6.00 and the lowest forecast at USD 6.00.
How have bioAffinity Technologies IncBIAF's recent earnings per share performed?
The market expectation was USD -0.81, while bioAffinity Technologies IncBIAF's earnings per share (EPS) for the previous quarter was USD -0.70. EPS for the next quarter is expected at USD -2.10.
What is the analyst rating for bioAffinity Technologies Inc?
Based on the ratings of bioAffinity Technologies Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.